InsiderInsights.com Daily Round Up 2/23/17: GNC, PJT, AAT, ARNC

|
Includes: AAT, AGIO, ALGN, AON, ARNC, ATKR, AXP, BCO, CAT, FB, GNC, HUM, KEF, MSFT, MYGN, PJT, SQ, TRU, TRUP
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on 2/23/17, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:
Insider filing volumes have recently increased again in response to more companies opening trading windows to their insiders after quarterly earnings releases. This high level of insider filing volumes should continue through most of March.

On Today's Tables:

Insider trades were rated Significant at:

  • PJT Partners (NYSE:PJT);
  • Korea Equity Fund (NYSE:KEF);
  • GNC (NYSE:GNC);
  • Arconic (NYSE:ARNC), and;
  • Amer Assets Tr (NYSE:AAT).

Insider trades were considered Insignificant at:

  • Myriad Genetics (NASDAQ:MYGN);
  • TransUnion (NYSE:TRU);
  • Square (NYSE:SQ);
  • Microsoft (NASDAQ:MSFT);
  • Humana (NYSE:HUM);
  • Facebook (NASDAQ:FB);
  • Brink's (NYSE:BCO);
  • Atkore Intl (NYSE:ATKR);
  • Aon (NYSE:AON);
  • Align Tech (NASDAQ:ALGN), and;
  • Agios Pharm (NASDAQ:AGIO).

There is a Conflicted Insider Signal (both purchases & sales) at:

  • Trupanion (NYSE:TRUP);
  • Caterpillar (NYSE:CAT), and;
  • American Express (NYSE:AXP).
Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Elliott Intl BO Arconic ARNC B $12,243,019
2 Moran Robert F CEO,DIR GNC GNC B $5,000,000
3 Hines Michael F DIR GNC GNC B $1,022,250
4 Bulldog Investors BO Korea Equity Fund KEF B $476,862
5 Brennan John Joseph DIR American Express AXP B $318,940
6 Taubman Paul J CB,CEO Pjt Partners PJT B $312,225
7 Rady Ernest S CB,CEO,BO Amer Assets Tr AAT B $186,226
8 Henderson John T DIR Myriad Genetics MYGN B $111,930
9 Ferracone Robin A DIR Trupanion TRUP B $100,371
10 De Lange Bob PR Caterpillar CAT JB* $99,320

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Advent Intl BO Transunion TRU JS* $711,688,768
2 Morfit G Mason DIR Microsoft MSFT S $297,282,304
3 Cd & R Allied BO Atkore Intl ATKR JS* $258,750,000
4 Koum Jan DIR Facebook FB AS $99,385,024
5 Case Gregory C CEO,DIR AON AON AS $60,102,964
6 Feld Peter A DIR Brinks BCO S $33,669,496
7 Prescott Thomas M DIR Align Tech ALGN JS* $6,727,212
8 Nelsen Robert DIR Agios Pharm AGIO S $6,683,464
9 Dorsey Jack CEO,CB,BO Square SQ AS $5,552,908
10 Jones David A Jr Ky DIR Humana HUM S $5,536,169

InsiderInsights.com | Key to Insider Title and Trans Type Codes:
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

About this article:

Expand
Author payment: Seeking Alpha pays for exclusive articles. Payment calculations are based on a combination of coverage area, popularity and quality.
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here